$UAMY

United States Antimony Corp (UAMY) (Q2 2026) Earnings Call Highlights: Antimony Volumes

United States Antimony Corp (UAMY) reported Q2 2026 antimony sales of 428,425 pounds, up 26% YoY, and zeolite revenue up 110% YoY. Revenue fell 25% to $7.9 million as average antimony prices dropped 52%, compressing gross margin to 7%. The company said it has $62.2M cash, total assets of $190.6M, and DLA orders of $57.3M, but lowered full-year revenue guidance to $60-$75M.

Original reporting
Published Aug 12, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 5:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
United States Antimony Corp (UAMY) (Q2 2026) Earnings Call Highlights: Antimony Volumes — source image
Decision brief

The 30-second read

$UAMYBearishMed
01

Why it matters

Traders should focus on the guidance reset ($60-$75 million) and the stated expectation that antimony prices remain around $10 per pound through 2026, which frames earnings sensitivity for the rest of the year.

02

Market read

The call provides a concrete earnings outlook update: weaker pricing compresses gross margin and drives a full-year revenue guidance reduction, despite progress on DLA deliveries and strong liquidity.

03

What to watch

The company attributes the guidance change entirely to pricing, but delayed revenue recognition from DLA deliveries to Q3 could create quarter-to-quarter noise rather than a permanent demand collapse.

Relevance 7/10Novelty 7/10Timing: pre-market today, after-hours earnings call guidance reset

Background

United States Antimony Corp held its Q2 2026 earnings call, reporting volume and segment growth alongside a sharp pricing-driven revenue and margin deterioration.

Company-level read

Ticker impact

$UAMYBearishMedium confidence
Context

UAMY guided full-year revenue down to $60-$75 million, citing lower antimony pricing, while detailing DLA deliveries and margin compression to 7%.

Expected impact

Near-term downside bias as guidance reset and margin compression signal weaker earnings power under current pricing assumptions.

Evidence & confidence

The call discloses a specific guidance reduction tied to pricing, plus gross margin falling to 7% and an operating loss, which typically pressures valuation until pricing stabilizes or deliveries accelerate.

Market effects

Highlights how antimony price volatility and China influence can quickly transmit into margins for specialty materials producers.

No direct regional macro read-through beyond US domestic production timelines (Montana) and Alaska exploration status.

Reinforces global supply-demand and pricing sensitivity to China for strategic materials used in defense and industrial supply chains.

Counterpoint

If DLA deliveries ramp faster than implied and inventory build supports smoother fulfillment, the revenue shortfall could be less severe than the guidance cut suggests.

Key entities

  • United States Antimony Corp

    Reported Q2 2026 results, DLA contract execution details, and lowered full-year revenue guidance due to lower antimony selling prices.

  • Gary Evans

    Chairman and CEO who discussed pricing outlook, guidance reduction rationale, and government grant/equity structuring expectations.

  • Damian Coleman

    Managing Director - Government Affairs who provided DLA delivery and revenue recognition timing details.

  • Shawn Winkler

    Interim CFO who explained liquidity and inventory build strategy.

Related articles

$UAMYMed

UNITED STATES ANTIMONY CORP (UAMY): Results of Operations and Financial Condition

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622899d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 United States Antimony Corporation Reports Second Quarter and Six Months Ended June 30, 2026 Financial and Operating Results Second Quarter 2026 Revenues of $7.9 Million; Net Income of $0.1 Million Antimony pounds sold up

$UAMYMed

Why Shares of United States Antimony Are Soaring This Week

United States Antimony (UAMY) shares rose about 12.2% from last Friday to 1:21 p.m. after the company reported completing initial Q2 2026 shipments under a $245M Defense Logistics Agency supply contract. It delivered ~82,000 pounds of antimony ingots, generating ~$2.6M, and is awaiting inspections for two more shipments. UAMY has received $57.3M in orders since contract start.

$UAMYMed

United States Antimony Corp.: United States Antimony Corporation Provides Update on Antimony Shipments to the DoW

United States Antimony Corp. (NYSE:UAMY) said it delivered the first shipments in Q2 2026 under a $245 million Defense Logistics Agency (DLA) supply contract. It shipped ~82,000 pounds of antimony metal ingots, generating about $2.6 million in June invoices. Total DLA orders since contract start are $57.3 million; two more shipments await inspection and authorization.

$USASMedAI 9/10

Americas extends hot streak with Cosalá hits

Americas Gold and Silver said new Cosalá infill drill results, reported after an Oct. 31 cutoff, returned grades up to 5x above its resource model at San Rafael Upper and 120 zones and are feeding mine planning for the second half. Examples include SR568 (14m of 599.8 g/t silver, 0.83% Cu) and 120-25-G95 (45m of 342.9 g/t silver, 0.85% Cu). The company also budgeted ~$20m for a 64,000m drill program.

$UAMYMedAI 8/10

I'm Thinking About Pulling the Trigger on This Producer of a Mineral Deemed "Critical" to the U.S.

The article says U.S. demand for antimony—classified by the U.S. as a critical mineral—has driven investor interest as the U.S. imports about 90% of its needs, while China is the largest producer. United States Antimony (UAMY) reported weaker first-quarter results, with revenue declining and a loss. It secured a federal sole-source contract worth up to $245 million, with a $10 million initial order, and had $39 million revenue in 2025.

$UAMYMedAI 8/10

I'm Thinking About Pulling the Trigger on This Producer of a Mineral Deemed "Critical" to the U.S.

The article says U.S. Antimony (NYSE: UAMY) is gaining investor attention as the U.S. seeks alternatives to China for “critical” minerals. It cites antimony’s military and semiconductor uses and notes the company’s first-quarter results showed revenue decline and a loss. U.S. Antimony received a sole-source federal contract worth up to $245 million, with $10 million initially ordered, and reported $39 million revenue in 2025.